BCM
INO icon

Boxer Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Boxer Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13M Buy
2,844,994
+474,872
+20% +$563K 0.24% 48
2026
Q1 		$4.12M Sell
2,370,122
-50,000
-2% -$82.3K 0.54% 36
2025
Q4 		$4.21M Buy
2,420,122
+120,122
+5% +$265K 0.92% 29
2025
Q3 		$5.38M Buy
+2,300,000
New +$4.4M 1.72% 15

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital Management's INO Position: Q2 2026 in Review

Boxer Capital Management increased its Inovio Pharmaceuticals (INO) stake by 20% in Q2 2026, buying an estimated $563K and bringing the position to 2,844,994 shares worth $3.13M. The position accounts for 0.24% of the portfolio, ranked #48.

Boxer Capital Management first reported a position in INO in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.38M in Q3 2025. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Boxer Capital Management held 2,844,994 shares of Inovio Pharmaceuticals worth $3.13M as of Q2 2026.
  • Boxer Capital Management bought 474,872 Inovio Pharmaceuticals shares in Q2 2026, an estimated $563K.
  • Inovio Pharmaceuticals made up 0.24% of Boxer Capital Management's portfolio in Q2 2026, its #48 holding.
  • Boxer Capital Management first reported a position in Inovio Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Boxer Capital Management's Inovio Pharmaceuticals position peaked at $5.38M in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.